Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?

Journal of the Neurological Sciences

Volumn 349, Issue 1-2, 2015, Pages 239-242

  Mader, Edward C ^a   Richeh, Wael ^a   Ochoa, Joaquin Maury ^a   Sullivan, Lacey L ^b   Gutierrez, Amparo N ^a   Lovera, Jesus F ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Acute disseminated encephalomyelitis; HCV genotype 2a 2c; Hepatitis C virus infection; Interferon beta 1a; Peginterferon; Tumefactive multiple sclerosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA1A INTERFERON; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; VIRUS RNA; BETA INTERFERON;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARBOVIRUS; ARTICLE; BACTERIA; CASE REPORT; DIFFUSION WEIGHTED IMAGING; DIPLOPIA; FEMALE; GLIOSIS; HEMIPARESIS; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 2; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERTRANSAMINASEMIA; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; NERVE PARALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; STEREOTACTIC BIOPSY; TOXOPLASMA; TUMEFACTIVE MULTIPLE SCLEROSIS; WEST NILE FLAVIVIRUS; WHITE MATTER LESION; COMPLICATION; DIFFERENTIAL DIAGNOSIS; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; HEPACIVIRUS; PARESIS; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HEPACIVIRUS; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; PARESIS; TREATMENT OUTCOME;

EID: 84924010846     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.12.034     Document Type: Article

References (33)

1. F.D. Lublin, S.C. Reingold, J.A. Cohen, and G.R. Cutter Defining the clinical course of multiple sclerosis: the 2013 revisions Neurology 83 3 Jul 15 2014 278 286
2. M.R. Rahmlow, and O. Kantarci Fulminant demyelinating diseases Neurohospitalist 3 2 Apr 2013 81 91
3. T. Menge, B. Hemmer, S. Nessler, H. Wiendl, and O. Neuhaus Acute disseminated encephalomyelitis: an update Arch Neurol 62 2005 1673 1680
4. L.B. Krupp, M. Tardieu, M.P. Amato, B. Banwell, and T. Chitnis International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions Mult Scler 19 10 Sep 2013 1261 1267
5. S. Tenembaum, T. Chitnis, J. Ness, J.S. Hahn, and International Pediatric MS Study Group Acute disseminated encephalomyelitis Neurology 68 16 Suppl. 2 Apr 17 2007 S23 S36
6. S. Poser, W. Luer, H. Bruhn, J. Frahrn, Y. Bruck, and K. Felgenhauer Acute demyelinating disease: classification and non-invasive diagnosis Neurol Scand 86 1992 579 585
7. V.V. Brinar Non-MS recurrent demyelinating diseases Clin Neurol Neurosurg 106 2004 197 210
8. J. Kepes Large focal tumor-like lesions of the brain: intermediate between multiple sclerosis and acute encephalomyelitis: a study of 31 patients Ann Neurol 33 1993 18 27
9. C.F. Lucchinetti, R.H. Gavrilova, I. Metz, J.E. Parisi, B.W. Scheithauer, and S. Weigand Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis Brain 131 Pt 7 Jul 2008 1759 1775
10. R.W. McMurray Hepatitis C-associated autoimmune disorders Clin Rheum Dis Clin North Am 24 2 May 1998 353 374
11. S. Sacconi, L. Salviati, and E. Merelli Acute disseminated encephalomyelitis associated with hepatitis C virus infection Arch Neurol 58 10 Oct 2001 1679 1681
12. J.E. Sim, J.B. Lee, Y.N. Cho, S.H. Suh, J.K. Kim, and K.Y. Lee A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection Yonsei Med J 53 4 Jul 1 2012 856 858
13. J.N. Acharya, and V.H. Pacheco Neurologic complications of hepatitis C Neurologist 14 3 May 2008 151 156
14. P. Cacoub, D. Saadoun, N. Limal, J.M. Léger, and T. Maisonobe Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications AIDS 19 Suppl. 3 Oct 2005 S128 S134
15. W. Hu, and C.F. Lucchinetti The pathological spectrum of CNS inflammatory demyelinating diseases Semin Immunopathol 31 4 Nov 2009 439 453
16. M. Albeldawi, E. Ruiz-Rodriguez, and W.D. Carey Hepatitis C virus: prevention, screening, and interpretation of assays Cleve Clin J Med 77 9 Sep 2010 616 626
17. J. Kaźmierczak, A. Pawełczyk, K.C. Cortes, and M. Radkowski Seronegative hepatitis C virus infection Arch Immunol Ther Exp (Warsz) 62 2 Apr 2014 145 151
18. M. Irshad, D.S. Mankotia, and K. Irshad An insight into the diagnosis and pathogenesis of hepatitis C virus infection World J Gastroenterol 19 44 Nov 28 2013 7896 7909
19. N.N. Zein Clinical significance of hepatitis C virus genotypes Clin Microbiol Rev 13 2 Apr 2000 223 235
20. A. El-Shamy, and H. Hotta Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview World J Gastroenterol 20 24 Jun 28 2014 7555 7569
21. T. Sy, and M.M. Jamal Epidemiology of hepatitis C virus (HCV) infection Int J Med Sci 3 2006 41 46
22. L. Rubbia-Brandt, G. Leandro, L. Spahr, E. Giostra, R. Quadri, and P.J. Malé Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3 Histopathology 39 2001 119 124
23. S. Bruno, A. Crosignani, P. Maisonneuve, S. Rossi, E. Silini, and M.U. Mondelli Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study Hepatology 46 2007 1350 1356
24. J.G. McHutchison, E.J. Lawitz, M.L. Shiffman, and A.J. Muir Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection N Engl J Med 361 2009 580 593
25. C. Giannitti, G. Morozzi, S. D'Alfonso, F. Bellisai, and M. Galeazzi Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection Reumatismo 60 3 Jul-Sep 2008 192 198
26. American Association for the Study of Liver Disease Recommendations for testing, managing, and treating hepatitis C Last updated 04/03/2014; source URL: http://www.hcvguidelines.org/full-report
27. F. Habersetzer, N. Boyer, P. Marcellin, F. Bailly, S.N. Ahmed, and J. Alam A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C Liver 20 6 Dec 2000 437 441
28. P.N. Cheng, P. Marcellin, B. Bacon, G. Farrell, I. Parsons, and T. Wee Racial differences in responses to interferon-beta-1a in chronic hepatitis C unresponsive to interferon-alpha: a better response in Chinese patients J Viral Hepat 11 5 Sep 2004 418 426
29. R. Pellicano, A. Craxi, P.L. Almasio, M. Valenza, and G. Venezia Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C World J Gastroenterol 11 29 Aug 7 2005 4484 4489
30. F.U. Tan, H. Cetinkaya, E. Erden, S. Ulkatan, and N. Aydin Dual benefit from intramuscular interferon-beta treatment in a patient with multiple sclerosis and chronic hepatitis-C virus infection Hepatogastroenterology 49 48 Nov-Dec 2002 1686 1687
31. H. Nomura, Y. Miyagi, H. Tanimoto, and N. Yamashita Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C J Infect Chemother 20 8 Aug 2014 489 492
32. P. Wietzke-Braun, L.B. Manhardt, A. Rosenberger, A. Uy, G. Ramadori, and S. Mihm Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates World J Gastroenterol 13 31 Aug 21 2007 4224 4229
33. T. Pham, S.A. MacParland, P.M. Mulrooney, H. Cooksley, N.V. Naoumov, and T.I. Michalak Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C J Virol 78 11 Jun 2004 5867 5874